Cogent Biosciences Stock 346% Surge Fueled by New Stake
A Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
Deciding between mobile and hardware wallets depends on usage and risk tolerance. This intro outlines safety considerations for both.
21,216 articlesA Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
UnitedHealth Group faces headwinds that go beyond routine market cycles. This guide breaks down the challenges, what ...
Coinbase’s latest metrics reveal retail traders are accumulating BTC and ETH despite volatility, while institutions d...
CubeSmart sits in a crowded self-storage field. This guide breaks down the key indicators I watch to assess whether C...
As shipping cycles turn, Safe Bulkers faces a critical earnings season. This guide deconstructs the Q4 2025 call, hig...
Tori Spelling says her California rental, home to five children, costs $12,000 a month and feels chaotic. The remark ...
Cogent’s Q4 2025 results show steady growth with improving margins and cautious guidance for 2026. This article inter...
New home sales edged lower in December but remain near multiyear highs at 745,000 SAAR, driven by financing incentive...
Two big catalysts could push XP stock higher: regulatory clarity in Brazil’s fintech scene and stronger cross-selling...
A Danish Seahawk helicopter evacuated a U.S. submariner off Nuuk for urgent medical care, a rare Arctic-incident that...
Dividend stocks paused last week as Crown Castle and AT&T tumbled while Coca-Cola rose. The move highlights a cooling...
A pro-Ripple lawyer’s critique of a potential Sam Bankman-Fried pardon is shaping XRP traders’ views as price targets...